The formation of a functional vasculature entails the initial sprouting of new blood vessels and the subsequent development of properly connected arteries and veins. Despite the importance of these processes, we still lack an understanding of the mechanisms balancing blood vessel expansion with artery-vein maturation and the establishment of efficient blood flow patterns. Previous studies have shown that Notch signalling controls angiogenic growth by determining the positions of endothelial cells (ECs) in growing blood vessel sprouts [1] [2] [3] . In this setting, vascular endothelial growth factor (VEGF) triggers expression of the Notch ligand dll4 in leading tip cells [4] [5] [6] , which in turn activates Notch signalling in trailing stalk cells, thereby preventing the formation of supernumerary tip cells [7] [8] [9] [10] . Studies using embryoid bodies suggested that ECs compete for the tip cell position during blood vessel sprouting 4 . Furthermore, Notch signalling is essential for arterial differentiation in zebrafish 11, 12 and mouse embryos [13] [14] [15] prior to the onset of blood flow. Intriguingly, several tip cell-enriched genes, such as Dll4 (ref. 7) , Cxcr4 (refs 16, 17) or Apelin 18, 19 , display an arterial restricted expression pattern, raising the possibility that tip cell and arterial fate specification might be coupled. Time-lapse imaging of blood vessel sprouting in zebrafish and genetic lineage tracing in mice showing that vein-derived tip cells contribute to newly forming arteries 20 further supported this notion. However, to date, it is not clear whether Notch signalling can simultaneously control tip cell specification and artery formation. In addition, we have only an incomplete understanding of the Notch downstream signalling molecules in ECs that might mediate these processes.
One key molecule influencing EC migration during angiogenesis is the chemokine receptor cxcr4a [21] [22] [23] [24] . In the early zebrafish embryo 16, 25, 26 and during tissue regeneration 20 , cxcr4a is important for arterial morphogenesis. It also has a role in guiding the formation of the coronary arteries 27, 28 and controls artery-nerve alignment in the mouse skin 29 . Despite the importance of CXCR4 function in these different vascular beds, it is still not clear which signalling pathways control CXCR4 expression in sprouting ECs.
Here we show, using time-lapse imaging in zebrafish embryos, that endothelial tip cells activate the Notch signalling pathway during blood vessel sprouting. We identify the chemokine receptor cxcr4a as an important Notch target during this process. Initially, Notch signalling induces cxcr4a expression, allowing proper tip cell migration towards the arterial circulation, thereby establishing optimal blood flow. At later stages, we observe downregulation of cxcr4a expression via Notch signalling and blood flow, which is important to prevent blood vessel hypersprouting. Together, our results link the role of Notch signalling during artery formation to its role in restricting angiogenesis, and elucidate a complex regulatory interplay between Notch and cxcr4a signalling.
RESULTS
Live imaging reveals activation of Notch signalling in endothelial tip cells To investigate Notch signalling during angiogenic sprouting in real time, we chose to study the development of the ocular vasculature in zebrafish embryos (Fig. 1a ). In this setting, ECs sprout from the venous primordial midbrain channel (PMBC) and connect to the cranial division of the carotid artery (CrDI), ultimately forming the nasal ciliary artery (NCA) [30] [31] [32] . The main Notch ligand in the vasculature is dll4 (ref. 1) . We developed a dll4 reporter transgenic line Tg(dll4:gal4) mu106 ; Tg(UAS:GFP) nkuasgfp1a . We detected a good correlation between dll4 messenger RNA, GFP mRNA and protein in ECs ( Supplementary Fig. 1a,b ). We then combined this line with Tg(kdrl:NLS-mcherry) is4 , which labels all EC nuclei, and performed time-lapse imaging for 12 h (Supplementary Videos 1-3, see also Supplementary Fig. 1c-f ). dll4 expression initiated in the leading tip cell (Fig. 1a , cell 1, 2:36 h time point, Fig. 1c ) followed by activation of the reporter line in stalk cells (cells 2 and 3, starting at the 5:12 h time point). By contrast, we did not find dll4 expression in cells that kept the connection to the PMBC (Fig. 1a , cell 4, 9:58 h time point, Fig. 1c ). Expression of dll4 was also detected in the CrDI, the blood vessel to which the NCA connected ( Fig. 1a , arrows) and was still detected in both vessels 12 h after their fusion (50 hours post fertilization (hpf) time point, Supplementary  Fig. 2a ). NCA sprouting and dll4 expression required VEGF signalling ( Supplementary Fig. 2c-f ). Therefore, in agreement with previous results in the mouse retina 5, 7, 10, 33, 34 , our analysis revealed that dll4 became activated in tip cells of growing blood vessel sprouts in the zebrafish eye.
We next analysed activation of Notch signalling during the same time frame, using an established Notch indicator line, Tg(TP1:GFP) um14 (ref. 35) (Fig. 1b,d , Supplementary Videos 4-6 and Supplementary Fig. 2g-j) . We expected to observe Notch activation in trailing stalk cells. Surprisingly, Notch activation was first initiated in the leading tip cell ( Fig. 1d ). We observed Notch pathway activation several hours after the onset of dll4 expression (compare Fig. 1c,d) . We further noted that ECs within the NCA showing Notch pathway activation fused to the Notch-positive CrDI (Fig. 1b, arrows) . Both vessels remained Notch positive at 12 h after fusion (50 hpf time point, Supplementary Fig. 2b ). To detect possible fluctuations in Notch pathway activation, we analysed Tg(TP1bglob:VenusPEST) s940 embryos 36 , in which the PEST domain reduces fluorescent protein half life 37 . These embryos also displayed stable activation of the Notch pathway within tip cells ( Supplementary Fig. 3 and Supplementary Videos 7-9). Finally, we generated Tg(dll4:gal4) mu106 ; Tg(UAS:GFP) nkuasgfp1a ; Tg(TP1:H2B-mcherry) s939 triple transgenic embryos to image dll4 expression and Notch pathway activation simultaneously. These embryos comparably showed activation of dll4 expression followed by Notch pathway activation in leading NCA tip cells ( Supplementary Fig. 4 and Supplementary Videos 10-12). Thus, our results show that expression of dll4 precedes Notch activation and that Notch signalling initially occurs in tip cells prior to pathway activation in stalk cells (Fig. 1e ).
Notch signalling occurs in trans
Knockdown of dll4 led to an almost complete absence of Tg(TP1:GFP) um14 activation ( Fig. 2a,b and Supplementary Fig. 5a-d and Supplementary Videos [13] [14] [15] , showing that Dll4 is the relevant endothelial Notch ligand. Notch signalling can occur in trans or in cis 38, 39 . To distinguish between these possibilities, we transplanted dll4 knockdown cells that were also transgenic for the Notch indicator line into wild-type (WT) embryos (Fig. 2c ). In the case of cis-activation, we would expect to observe absence of Notch activation within dll4-deficient tip cells, while activation in trans would allow for Notch activation from neighbouring, dll4-positive host ECs (Fig. 2d ). We observed Notch pathway activation in dll4 knockdown tip cells when they were in association with WT host cells ( Fig. 2e-k and Supplementary Fig. 5e -v). Thus, our results suggest that Notch pathway activation in tip cells occurs in trans.
Notch-ligand-deficient cells can maintain tip cell positions
These transplantation experiments furthermore revealed an unexpected ability of ECs lacking dll4 to occupy tip cell positions. Previous studies proposed that ECs shuffle between tip and stalk positions during angiogenic sprouting and that these behaviours depend on Notch activity in trailing stalk cells 4 . According to this model, dll4deficient cells would be excluded from the tip position ( Fig. 3a ). To corroborate our findings in mosaic NCAs, we examined the distribution of either control-or dll4-morpholino-injected Tg(kdrl:EGFP) s843 donor cells within sprouting intersegmental blood vessels (ISVs) (Fig. 3b ). This analysis revealed that control-morpholino-injected ( Fig. 3c, arrowhead, Fig. 3d ) and dll4-morpholino-injected ( Fig. 3c , arrow, Fig. 3d ) donor cells were equally distributed between tip and stalk cell positions. To investigate whether cell shuffling took place during ISV sprouting, we performed time-lapse analysis of mosaic embryos. These videos showed that dll4-deficient cells could remain in tip cell positions throughout the sprouting process ( Fig. 3e , arrowheads, see also Supplementary Fig. 6a-d ). Of note, and in agreement with a recent publication 40 , we also did not detect EC shuffling during ISV sprouting in WT embryos ( Supplementary Fig. 6h ,i).
Several Notch ligands are expressed in zebrafish ECs, which could potentially activate Notch receptors in the absence of dll4 function. We therefore analysed the distribution of mindbomb (mib) mutant donor cells. Mib mutants lack an essential ubiquitin ligase necessary for Notch ligand processing 41 . We observed that mib mutant cells were also equally distributed between tip and stalk cell positions during ISV sprouting ( Fig. 3f,g and Supplementary Fig. 6e -g). Together, these results indicate that Notch-ligand-deficient cells can occupy tip cell positions during blood vessel sprouting at a similar frequency as WT cells.
Loss of Notch signalling impairs the connection of new blood vessel sprouts to the existing arterial vasculature
On the basis of our observations that Notch signalling is activated within tip cells, we hypothesized that interfering with Notch signalling might compromise tip cell biology. Previous studies showed that Notch signalling controls EC proliferation and vascular expansion 5, [7] [8] [9] [10] 42 . In agreement, we found that NCA area and cell numbers were increased in embryos lacking dll4 function ( Fig. 4a-c improper connection to the CrDI (Fig. 4a , arrowheads, Fig. 4d and Supplementary Videos 13-15). This ultimately led to a direct connection between two veins and aberrant NCA blood flow patterns that lacked proper arterial input ( Fig. 4e-h ). Therefore, Notch activation regulates EC migration ( Fig. 4i ,j). dll4-morpholino-injected embryos between 28 and 38 hpf ( Fig. 5b , arrows). This indicates that Notch signalling can positively regulate cxcr4a expression.
We reasoned that if lack of cxcr4a expression was responsible for the observed failure of NCA cells to connect to the CrDI in embryos lacking proper Notch signalling, then cxcr4a mutants should recapitulate this phenotype. Analysis of cxcr4a mutant zebrafish showed an absence of NCA-CrDI connection at the 36 hpf time point ( Fig. 5c , arrows). By 48 hpf, the NCA in WT embryos carried blood flow ( . Analysis of EC numbers in cxcr4a mutants revealed no significant difference between siblings and mutants ( Fig. 5e,f) . Therefore, loss of cxcr4a function recapitulated the migratory phenotype of NCA cells in embryos lacking dll4-Notch signalling without affecting EC (Fig. 5g,h and Supplementary Fig. 7c,d ). Together, our findings suggest that Notch signalling induces cxcr4a expression during angiogenic sprouting.
Loss of cxcr4a function rescues hypersprouting phenotype in Notch-deficient blood vessels
We next wanted to examine whether the observed regulation of cxcr4a expression via Notch signalling was a general phenomenon. We therefore analysed cxcr4a expression in newly forming intersegmental blood vessel sprouts (ISVs). We detected cxcr4a expression in the dorsal aorta and in sprouting ISVs (Fig. 6a , 28 and 32 hpf time points, arrows). However, at later stages and after the onset of blood flow (2.5 days post fertilization (dpf) time point) 44 , we observed downregulation of cxcr4a expression in ISVs and in the dorsal longitudinal anastomotic vessel (DLAV; Fig. 6a , 2.5 dpf time point, arrow). By contrast, dll4-morpholino-injected embryos showed an initial reduction of cxcr4a expression ( Fig. 6b , arrows, 28 and 32 hpf time points), as we had observed in the eye vasculature. However, at later stages, cxcr4a expression was upregulated ( Fig. 6b , 2.5 dpf time point, arrows).
Motivated by these observations, we explored possible genetic interactions between Notch and cxcr4a signalling. To do so, we knocked down dll4 in homozygous cxcr4a mutants. Of interest, while the amount of ectopic sprouts ( Fig. 6c , arrows, Fig. 6e ) was strongly reduced in dll4-knockdown embryos lacking cxcr4a function, EC numbers were still increased ( Fig. 6f ). cxcr4a/dll4 double-mutant embryos showed a similar rescue of hypersprouting ( Fig. 6d ,g,h). Thus, our results show that the hyperangiogenesis phenotype observed in dll4-knockdown embryos is partly due to an increase of cxcr4a expression.
To investigate the mechanism by which loss of Notch signalling might influence cxcr4a expression, we examined ISV blood flow patterns in dll4 knockdown embryos. As previously reported 8 , we observed a reduction of ISVs carrying blood flow, both at the 54 hpf and at the 72 hpf time points ( Supplementary Fig. 7e -h). More than 90% of ISVs showing ectopic blood vessel sprouts at 72 hpf did not carry circulation at the 54 hpf time point, while of the ISVs showing no ectopic sprouts, only 60% did not carry blood flow at the 54 hpf time point ( Supplementary Fig. 7g ). At the 72 hpf time point, almost 80% of ISVs with ectopic sprouts still did not carry blood flow, while only 60% of ISVs without ectopic sprouts did not carry blood flow. We also detected a marked increase in cxcr4a mRNA in the DA and in the DLAV when we blocked blood flow between 48 and 52 hpf ( Supplementary Fig. 7h ). Together, our findings indicate that Notch signalling differentially regulates cxcr4a expression and that there is a genetic interaction, which may be direct or indirect, between both pathways. They furthermore suggest that aberrant blood flow patterns contribute to increases in cxcr4a expression in dll4-deficient embryos.
Notch signalling differentially regulates cxcr4 expression
Using a human umbilical artery endothelial cell (HUAEC) culture system, in which Notch signalling was activated by plating cells on DLL4, we found CXCR4 upregulation between 4 and 8 h of incubation ( Fig. 7a ). This was unexpected, as previous studies showed that Notch signalling negatively regulates CXCR4 expression in ECs 45, 46 . However, when we exposed HUAECs to DLL4 for longer times (24 h), we observed a comparable downregulation of CXCR4 expression ( Fig. 7a ). Thus, Notch signalling can differentially regulate CXCR4 expression in cultured ECs, depending on the duration of Notch pathway activation.
To further explore this aspect of Notch signalling, we analysed CXCR4 regulatory regions. This analysis identified three RBPJbinding sites, the downstream transcription factor of the Notch signalling pathway 38 (Fig. 7b ), of which site 2 is being conserved among mammals (see Methods). We then performed chromatin immunoprecipitation (ChIP) in basal conditions and 4 h after DLL4mediated Notch pathway activation. As a control, we used a previously described RBPJ-binding site in the HES4 promoter ( Fig. 7c) . Surprisingly, all RBPJ-binding sites within CXCR4 regulatory regions showed strong enrichment already in basal conditions (Fig. 7d ). Subsequent to Notch pathway activation, there was a trend towards reduction in enrichment, although this was not statistically significant ( Fig. 7d ). Control regions 5 and 3 of the CXCR4 promoter did not show enrichment ( Fig. 7d ). Thus, our analysis uncovers three RBPJbinding sites that might control CXCR4 expression. It furthermore suggests that these sites are differentially occupied by RBPJ depending on Notch signalling status.
To determine the significance of each site for CXCR4 expression, we generated a luciferase construct containing 2.5 kilobases upstream of the CXCR4 start codon, as well as the first intron. In keeping with our qPCR results, Notch pathway activation led to an increase in luciferase expression ( Fig. 7e ). Mutating RBPJ-binding site 1 caused a small reduction of luciferase expression, while mutating the conserved RBPJ-binding site 2 increased luciferase expression already in basal conditions. These results suggest that RBPJ acts as a transcriptional repressor and that Notch pathway activation might release this repressive activity. However, we noted that Notch pathway activation still increased luciferase expression irrespective of functional RBPJ-binding sites. This might argue for the existence of other indirect mechanisms downstream of Notch signalling controlling CXCR4 expression.
To investigate whether Notch signalling can directly influence cxcr4a expression during angiogenesis, we generated triple transgenic embryos Tg(cdh5:gal4ff) mu101 ; (UAS:GFP) nkuasgfp1a ; (UAS:myc-NICD) kca3 . In these embryos, myc-tagged Notch intracellular domain (NICD) is specifically expressed in the vasculature, albeit in a mosaic fashion. We also injected these embryos with dll4 morpholino. Eightyfive per cent of myc + ECs in ISV sprouts showed cxcr4a expression ( Fig. 7f, arrows, Fig. 7g ) compared with only 15% of myc-ECs ( Fig. 7f , asterisk, Fig. 7g ), thus suggesting a cell autonomous role of Notch signalling in inducing cxcr4a expression. Together, our findings argue for an initially repressive function of RBPJ on the CXCR4 promoter that might be relieved in a cell autonomous manner following Notch pathway activation. 
Notch signalling does not control venous blood vessel sprouting
Our results suggest that Notch signalling restricts angiogenesis in settings of coordinated artery formation. We therefore wanted to analyse whether Notch signalling also had a role during the expansion of a venous vascular plexus (Fig. 8a-c) . Analysis of caudal vein plexus (CVP) formation in dll4-morpholino-injected embryos in comparison to control-morpholino-injected embryos ( Fig. 8b and Supplementary Video 20) revealed normal migratory behaviours of ECs (Fig. 8c, 3 ( Fig. 8d-f ). Analysis of Tg(TP1:GFP) um14 embryos did not reveal activation of the Notch signalling pathway in these cells during CVP expansion (Fig. 8g ). Correspondingly, we did not detect dll4 reporter activity or cxcr4a mRNA expression in sprouting CVP cells (Supplementary Fig. 8a,b) . These findings reveal that during CVP expansion, Notch signalling is not necessary to restrict angiogenic sprouting.
DISCUSSION
In this report we used time-lapse imaging to examine the spatiotemporal sequence of Notch pathway activation within angiogenic blood vessel sprouts. Previous reports investigated activation of Notch signalling at fixed time points 7, 31, 35 . We have now found that dll4 expression preceded Notch pathway activation both in leading tip and subsequently in trailing stalk cells. These cells ultimately connected to a Notch-positive arterial blood vessel, thereby terminating the angiogenesis program. Our results therefore show how Notch pathway activation and artery formation are integrated during angiogenesis ( Supplementary Fig. 8c,d) . They help to explain how growing tissues can generate the appropriate amount of arteries, as these are continuously being generated from venous-derived tip cells that activate Notch signalling. These will subsequently be exposed to arterial blood flow patterns, which can induce the expression of arterial genes 47 .
These discoveries redefine the role of Notch signalling during angiogenesis in comparison with current models of blood vessel sprouting, where DLL4 from tip cells would activate Notch signalling in trailing stalk cells and prevent the formation of excessive tip cells ( Supplementary Fig. 8c,d) 2 . Our work suggests important differences concerning Notch signalling pathway activation during blood vessel sprouting in distinct settings. We previously suggested that tip cells in ISV sprouts lack Notch signalling 9 . However, this might be a special scenario, since ISVs do not sprout from a vein, but rather from an artery.
An outstanding unresolved question is why we do not observe activation of Notch signalling in stalk cells first, as tip cells express Dll4 prior to stalk cells. One potential explanation is that stalk cells are less competent to receive Notch signalling compared with tip cells, a possibility we are currently investigating. Alternatively, cisinhibition 38 , where interaction between the ligand and the receptor present on the same cell leads to endocytosis and further degradation of the receptor-ligand complex, might influence Notch pathway activation in tip and stalk cells.
Loss of Notch signalling leads to overproliferation of ECs and the formation of a hyperbranched vasculature. Previous studies showed that PTEN mediates the Notch-induced proliferation arrest in ECs 48 . We now identify the chemokine receptor cxcr4a as another critical downstream target of Notch signalling, which specifically regulates cell migration. Thus, our work suggests that distinct target genes are responsible for the different phenotypes observed in angiogenic blood vessels lacking proper Notch signalling. We furthermore uncover temporal differences in cxcr4 regulation by Notch. After an initial increase in expression, Notch signalling subsequently negatively regulates cxcr4 expression. Our work reveals that the duality of this regulation is important, since early loss of cxcr4a causes migratory defects in tip cells, while ectopic expression at later stages contributes to excessive blood vessel sprouting. A better understanding of the regulatory modules that mediate the observed temporal differences in cxcr4 expression downstream of Notch signalling will therefore be of great future interest.
A report analysing artery formation during angiogenic blood vessel sprouting in the mouse retina similarly found a role for Notch signalling in limiting CXCR4 expression 49 . In addition, the authors provide evidence that also in this setting, Notch pathway activation in endothelial tip cells is necessary for these cells to incorporate into nascent arteries. Thus, the function of Notch signalling in regulating angiogenesis via artery formation appears to be conserved between mice and zebrafish. However, Pitulescu et al. did not observe an initial induction of CXCR4 expression via Notch signalling. They propose that Notch signalling is rather required to limit endothelial VEGF mRNA levels, thereby secondarily affecting CXCR4 expression. Future work will be necessary to better understand to which extent these observations reflect temporal or species-specific differences in the control of CXCR4 expression downstream of Notch pathway activation.
Ectopic CXCR4 expression can be detected on tumour ECs 46 , which strongly respond to inhibition of Notch signalling 50 . Our findings will therefore also be of importance for improving treatments aiming at controlling blood vessel formation in pathological settings, when achieving correctly patterned vascular networks is a therapeutic aim.
METHODS

Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper METHODS Zebrafish strains. Zebrafish were maintained as described previously 51 Zebrafish used in this study were between 1 and 2 years of age and were not selected for gender. All animal experiments were performed in compliance with the relevant laws and institutional guidelines and were approved by local animal ethics committees of the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.
Generation of Tg(dll4:gal4) mu106 line. We applied BAC recombineering as described previously 64, 65 using BAC CH211-19M2 and modified with a PCR-fragment amplified from pCS2+_Gal4FF_kanR using primers dll4_gal4FF_fw: 3 -ctttctggg aatataatcgtgggtgacacggctgcccaggagaatcgaaaACCATGAAGCTACTGTCTTCTATC GAAC-5 and dll4_kanR_rev: 3 -tgcgtcaaaacggtcgtgaaaaatgcgatgagaaaggtgagccaagc tgcTCAGAAGAACTCGTCAAGAAGGCG-5 .
Live imaging, confocal microscopy and image processing . For in vivo imaging, live embryos were mounted in 1% low-melting-point agarose in E3 embryo medium with 168 mg l −1 tricaine (1times) for anaesthetization and 0.003% phenylthiourea to inhibit pigmentation. Imaging was carried out on SP5 or SP8 (Inverted) confocal microscopes using a 20× dry objective (Leica Microsystems). A heated microscope chamber at 28.5 • C was used for recording time-lapse videos. Stacks were taken every 15-25 min with a step size of 2.0 µm. Confocal stacks and time-lapse videos were analysed using IMARIS Software (Bitplane) and ImageJ (NIH). Vessels in close proximity to the CrDI and NCA were cropped for better visualization.
Quantifications.
To quantify the fluorescence intensity of the reporter lines for eye vessel live imaging experiments, surface rendering was performed around the endothelial cell nuclei using IMARIS software. The intensity of both red and green channels emitted from rendered nuclear surfaces was recorded over time. The green channel intensity value was divided by the red channel intensity value to normalize the data. Prism 6.0b (Graphpad) was used to plot graphs and for statistical analysis.
Morpholino injections.
Morpholinos were obtained from Gene-Tools and dissolved in distilled water. Embryos were injected at one cell stage with 15 ng dll4 morpholino (5 -CGAATCTTACCTACAGGTAGATCCG-3 ) 9 or 5 ng of kdrl morpholino (5 -CCGAATGATACTCCGTATGTCAC-3 ) 66 . As a control, standard control morpholino (5 -CCTCTTACCTCAGTTACAATTTATA-3 ) was injected.
Fluorescence in situ hybridizations (FISH) with antibody staining. Wholemount FISH combined with EGFP antibody staining was performed in the Tg(kdrl:EGFP) s843 line as described previously 67 . Double FISH was performed in the Tg (dll4:gal4) mu106 ; (UAS:GFP) nkuasgfp1a embryos as described earlier 68 . The double FISH was followed by GFP antibody detection as described for the single FISH protocol. Previously described probes for cxcr4a (ref. 26 ) and dll4 (ref. 9) were used. Images were acquired using SP5 or SP8 (Leica Microsystems) or LSM 780 (Zeiss) inverted confocal microscopes using a 20× dry objective.
Blastomere transplantation. Cell transplantation was performed as described previously 9 . About 30-40 cells were transplanted from donor embryos to the margin of host embryos at sphere stage. The endothelial cell contribution of transplanted cells was assessed by visualization of EGFP and mcherry expression. Fli1b antibody staining was performed as described previously 69 .
Flow block experiments and inhibitor treatment.
Flow block experiments were carried out as previously described 16 . The time of treatment was increased to 4 h. VEGF inhibitor treatment was performed as described previously 70 . Corresponding amounts of dimethylsulfoxide were used to treat the control embryos.
Notch gain-of-function experiments. For Notch gain-of-function experiments,
Tg(cdh5:GAL4) mu101 ;Tg(UAS:GFP) nkuasgf 1a fish were crossed with Tg(UAS:myc-NICD) kca3 fish. Whole-mount FISH combined with antibody staining for EGFP was performed as mentioned above. To detect NICD-positive embryos, additional antibody was used against c-myc (1:250 dilution;
Sigma-Aldrich M5546) followed by Alexa Fluor 647 (1:500 dilution; Invitrogen A-21236) goat anti-mouse secondary antibody staining during the FISH protocol.
Cell culture experiments. Human umbilical artery endothelial cells (HUAECs) were isolated from umbilical cords of anonymized donors as described previously 71 and according to the principles outlined in the Declaration of Helsinki; this was approved by the ethics board of the WW-University of Münster (2009-537-f-S). HUAECs were cultured in M200 medium with LSGS supplements (Invitrogen) and used for experiments until passage 5. For stimulation with DLL4, cell culture dishes (ibidi) were coated overnight at 4 • C with 10 µg ml −1 DLL4 (R&D) diluted in PBS with 0.2% gelatin (Sigma). The cells were starved overnight in M200 medium supplemented with 0.1% FCS (Sigma) and reseeded on the dishes coated with DLL4 or only gelatin in the starvation medium. No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. The cell lines were not authenticated. The cell lines were not tested for mycoplasma contamination. Chromatin immunoprecipitation (ChIP). HUAECs were starved overnight in 0.1% FCS-containing medium and seeded on DLL4-coated or uncoated dishes in the same medium. After 4 h the cells were fixed with 1% formaldehyde for 5 min at room temperature. The crosslinking was stopped with 0.125 M glycine and after washing with cold PBS, cells were collected by scraping in PBS containing protease inhibitors. The cells were then resuspended in the nuclei lysis buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, 1% SDS) and sonicated with Covaris S1 to obtain DNA fragments of 250 bp on average. Chromatin was diluted (final buffer composition: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.15 M NaCl, 0.1% SDS, 1% Triton X-100, 0.1% sodium deoxycholate) and an aliquot was used to confirm sonication efficiency on Bioanalyzer (Agilent) and to quantify chromatin amount. Five micrograms of chromatin was incubated with 2 µg RBPJ antibody (Abcam, ab25949) overnight and then 50 µl of pre-washed Dynabeads-Protein G (Life Technologies) was added for 4 h to each reaction to pull down DNA/protein complexes. The beads were then washed 5 times with the buffers with increasing ionic strength and resuspended in the buffer containing 10 mM Tris-HCl pH 8.0, 0.3 M NaCl, 5 mM EDTA pH 8.0, 0.5% SDS. The beads were then incubated with RNase A at 65 • C for 6 h and with Proteinase K at 55 • C overnight. DNA was then isolated by phenol/chloroform extraction and ethanol precipitation and resuspended in TE buffer. An aliquot of chromatin was saved as input and DNA was isolated in the same way. Input and ChIP DNA was used for qPCR using SYBR Green as described above. HES4 primers (7273, Cell Signaling) were used as positive and alpha Satellite repeat primers (Abcam, ab85782) as negative control. To identify potential RBPJ-binding sites, we analysed CXCR4 regulatory sequences with the FIMO algorithm of the MEME Suite using the SUH_HUMAN.H10MO.C matrix from the HOCOMOCO database. In addition we investigated conservation of RBPJ-binding sites between human and mouse using Mulan and multiTF algorithms and V$RBPJK_01 matrix. The primers amplifying the regions containing RBPJ-binding sites predicted by FIMO were: CXCR4-1-fwd: 5 -GTAGAATCCTACAACTCTCCTCCCCATCT-3 ; CXCR4-1-rev: 5 -ACCCTCAGCGTCTCAGTGCCCTT-3 ; CXCR4-2-fwd: 5 -GCGTTGCAAAGACTCATTCTCCTAAA-3 ; CXCR4-2-rev: 5 -CCAATATACCCCAAGCACCGAAG-3 ; CXCR4-3-fwd: 5 -TGGTGGCTGGAAGAGGTTTCG-3 ; CXCR4-3-rev: 5 -AAGAGATACGTAATGCAAGGCCTGT-3 .
In addition the primers to amplify the regions upstream and downstream of CXCR4 containing no predicted RBPJ-binding sites were used: CXCR4-4-fwd: 5 -CTGCACTCCAGCCTAACTGTCAGAG-3 ; CXCR4-4-rev: 5 -TCCTATTCCTGGGAGCACACAAAA-3 ; CXCR4-5-fwd: 5 -GGTTTAGATTAGGCTTCTCCAGACTGAA-3 ; CXCR4-5-rev: 5 -ACAGCCCAGATGGGCGAAAG-3 . The data were calculated as percentage of input and then normalized to a negative region (alpha Satellite repeat) to obtain fold enrichment.
DOI: 10.1038/ncb3574
Luciferase assay. For luciferase assays, we cloned a 2.5-kilobase upstream piece of the human CXCR4 promoter including the first intron via PCR and restriction digest into pGL4.10 (Promega). The promoter piece was amplified with PfuII polymerase from a BAC containing the human CXCR4 locus (IMGSB737B122186D; Source Bioscience) using primers Hs cxcr4 Pr 2.5 F (GGATGAACCAAAATCTTGTCAAC-TATTCCACTAACAGT) and Intron R (GTGGTCTGAGTCCCGAGGCAGCG) and subsequently cloned into pSC Blunt (Stratagene). The intron piece was amplified with primers Intron F (TGACGCCGAGGGCCTGAGTGCT) and Hs cxcr4 Bsp R (TTAATCATGATTTCCCCTGAGCCCATTTCCTCGGTGTAG) and cloned into pSC Blunt. The promoter piece was then digested using SpeI and Acc65I, while the intron piece was digested using Acc65I and BspHI and pGL 4.10 using NheI and NcoI. The three pieces were subsequently ligated together and confirmed via sequencing.
The predicted intronic RBPJ-binding sites were mutated as follows: 5 site gcgtgggaaaa into gcgtCCgaC, the 3 site ctatgggaaaa into ctaCCggCTAa. We also mutated both sites simultaneously. Mutated nucleotides are shown in capital letters. The constructs were chosen to contain unique restriction sites (PflMI on the 5 end and AseI on the 3 end), leading to 776-bp fragments, which we custom ordered from MWG Biotech. The parental plasmid and the respective mutated construct were digested with PflMI and AseI and ligated.
HUAECs were starved in the medium with no FCS for 4 h and transfected for 45 min with CXCR4 constructs using Lipofectamine 2000 and Plus Reagent (Invitrogen). Immediately after transfection, the cells were reseeded in 0.1% FCScontaining medium on the dishes, pre-coated with DLL4 as described above. Twenty-four hours after seeding, the cells were lysed and luciferase activity was measured with the Dual-Luciferase Reporter Assay System (Promega). For normalization the cells were co-transfected with pRL-CMV vector (Promega) and the values of firefly luciferase activity were divided by the values of Renilla luciferase.
Statistics and reproducibility.
Sample sizes were not predetermined, the experiments were not randomized and investigators were not blinded to allocation during experiments and outcome assessment. Column statistics were performed on data sets to check for normal distribution and appropriate tests were performed. Each experiment was performed at least three times with the exception of RNA in situ hybridization for dll4 Tg line validation ( Supplementary Fig. 1a,b) , VEGF inhibitor treatment ( Supplementary Fig. 2e,f) , videos of ISV sprouting ( Supplementary  Fig. 6h ,i) and blood flow analysis in ISVs of dll4-morpholino-injected embryos ( Supplementary Fig. 7g ), which were performed two times. In the format provided by the authors and unedited. Supplementary Figure 1 Hasan et al. Supplementary Figure 5 Hasan et al. 
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No commonly misidentified cell lines were used.
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Zebrafish used in this study were between 1 and 2 years of age and were not selected for gender. The following transgenic lines were used: Tg(kdrl:NLS-mcherry)is4, Tg (dll4:gal4)mu106 (this study), Tg(UAS:GFP)nkuasgfp1a, Tg(TP1:GFP)um14, Tg(kdrl:H2B-EGFP)mu122, Tg(kdrl:EGFP)s843, Tg(fli:nEGFP)y7, Tg(kdrl:Hsa.HRAS-mCherry)s916 , Tg(fli1a:EGFP)y1, Tg(-0.8flt1:RFP)hu5333, Tg(gata1:DsRed)sd2, cxcr4a um20, dll4 j16e1, mib ta52b, Tg(TP1:Venus-PEST)s940, Tg(TP1:H2Bmcherry)s939, Tg(cdh5BAC:gal4ff)mu101, abbreviated as Tg(cdh5:GAL4)mu101, Tg(UAS:myc-Notch1a-intra)kca3, abbreviated as Tg(UAS:NICD)kca3. The fli1b antibody was obtained from the laboratory of Dr. Nathan Lawson, UMass Medical School, Worcester, USA.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Study did not involve human research participants.
